Fact CheckerSign in

NCT07859072Not yet recruiting

WB-EMS Combined With Nutritional Guidance for a High-Protein Diet on Body Composition, Muscle Function, Psychological and Functional Outcomes in Older Adults With Excess Adiposity

Effects of Whole-Body Electromyostimulation Combined With Nutritional Guidance for a High-Protein Diet on Body Composition, Muscle Function, Functional Performance, Psychological Outcomes, Cardiometabolic Health, Cognitive Function, Quality of Life, and Other Health Outcomes in Older Adults With Excess Adiposity: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

This is a 16-week randomized controlled trial (RCT) with outcome assessor blinding. The objective is to investigate the effects of resistance training (RT) combined with whole-body neuromuscular electrical stimulation (WB-NMES) and a high-protein diet on body composition, anthropometry, and quality of life. Sample and Group Allocation The sample will comprise 36 older adults (≥ 60 years), physically inactive, and with overweight or obesity (BMI ≥ 25 kg/m²). They will be randomized (stratified by sex) into four groups of 9 participants: RT + NOR: Resistance training + normal-protein diet. RT + PRO: Resistance training + high-protein diet. WB-NMES + RT + NOR: Resistance training with electrical stimulation + normal-protein diet. WB-NMES + RT + PRO: Resistance training with electrical stimulation + high-protein diet. Intervention Protocol Exercise (2x/week, 25 min/session): Seven exercises (2 sets of 1 min execution with 45s of rest). Progressive intensity controlled by the OMNI-RPE Scale. Electrical Stimulation (WB-NMES Groups): Simultaneous use of an electrode suit (85 Hz, 400 µs pulse width, 5s on/5s off duty cycle), with intensity capped at a maximum of 5/10 on the pain/discomfort Visual Analog Scale (VAS). Nutrition (In-person + Remote): High-protein (PRO) groups will focus on an intake of 1.2 to 1.5 g of protein/kg/day. Normal-protein (NOR) groups will receive general healthy eating guidelines, without encouraging an increase in protein intake. Assessments and Outcomes (Conducted at T0 and T16) Body Composition and Anthropometry: Multi-frequency bioelectrical impedance (InBody 570) and circumference measurements following ISAK guidelines. Physical and Functional Performance: Handgrip strength (dynamometry). Muscular endurance (30-second chair stand and arm curl tests). Upper limb power (2 kg medicine ball throw). Aerobic endurance (6-Minute Walk Test). Mobility and fall risk (Timed Up and Go - TUG). Questionnaires and Scales: Self-reported functional disability (WHODAS 2.0). Basic psychological needs satisfaction (BPNES). Motivational regulation in exercise (BREQ-3). Quality of life specific for older adults (WHOQOL-OLD). Adherence: Minimum attendance goal of 75% for the sessions. Statistical Analysis The analysis will follow the intention-to-treat (ITT) principle. Data will be analyzed using Linear Mixed Models for Repeated Measures (fixed factors: Group and Time), followed by Tukey's post-hoc test, adopting a significance level of $p \< 0.05$.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
36 (estimated)
First submitted
28 Aug 2026
Start date
2 Oct 2026
Primary completion date
5 Feb 2027
Lead sponsor
Universidade Cesumar (UNICESUMAR)
Diseases
Obesity
NCT number
NCT07859072

What you commit to

  • Study type: Interventional
  • Planned participants: 36
  • From 2 Oct 2026 to the primary completion date, 5 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of medications or supplements known to significantly affect protein metabolism or muscle mass;

Other illness

  • Presence of electronic implants (e.g., cardiac pacemakers, defibrillators) or metallic implants that contraindicate WB-NMES;
  • Absolute contraindications to WB-NMES (e.g., active neoplasia, severe epilepsy, acute inflammatory diseases, severe cardiac arrhythmias, thrombosis);
  • Severe cognitive impairment that prevents understanding instructions or questionnaires;
  • Disabling musculoskeletal or neurological disorders that hinder exercise performance;
  • Uncontrolled chronic diseases (e.g., uncontrolled hypertension or diabetes);

Other

  • Adherence below 85% in training sessions or nutritional follow-ups during the study period.

Who the study is looking for

  • Age 60 years or older (both sexes);
  • Body Mass Index (BMI) ≥ 25 kg/m² (overweight or obese);
  • Physically inactive (not engaged in regular structured exercise for at least 6 months prior to the study);
  • Medical clearance to engage in progressive resistance exercise and neuromuscular electrical stimulation.

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UniCesumar - Centro Universitário Cesumar
Coordinator of this site? Confirm its status
MaringáBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.